ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

HSCS vs MLSS // GROSS PROFIT MARGIN

HeartSciences Inc. (NASDAQ) VS. Milestone Scientific Inc. (NYSE) • 15-METRIC TALLY: HSCS 1 — MLSS 4
▲ GROSS PROFIT MARGIN LEADER: MLSS
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSCS VS. MLSS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC HSCS MLSS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE 59.10% 71.40% -12.30 MLSS /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -10.27% — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% 63.80% -123.80 MLSS /net-margins <GO>
Revenue Growth (YoY) -0.70% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 MLSS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 53.1 40.8 +12.30 HSCS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 4.7x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $17.5M $28.6M -$11.1M MLSS /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR HSCS REV MLSS REV HSCS GROSS % MLSS GROSS % HSCS FCF MLSS FCF
FY 2025 $4.3K $9.0M 59.1% 71.4% -$7.4M -$2.9M
FY 2024 $4.3K $8.6M 56.8% 74.6% -$7.4M -$2.9M
FY 2023 $18.6K $0 — — -$6.1M -$5.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSCS // BETA —
MLSS // BETA —